Imp-act of lesion complexity on the capacity of a trial to detect differences in stent performance:: Results from the ISAR-STEREO trial

被引:36
作者
Hausleiter, J
Kastrati, A
Mehilli, J
Schühlen, H
Pache, J
Dotzer, F
Sattelberger, U
Dirschinger, J
Schömig, A
机构
[1] Deutsch Herzzentrum Munich, D-80636 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Med Klin, D-8000 Munich, Germany
[3] Klinikum Garmisch Partenkirchen, Med Klin 1, Garmisch Partenkirchen, Germany
[4] Krankenhaus Ingolstadt, Med Klin 1, Ingolstadt, Germany
关键词
D O I
10.1016/S0002-8703(03)00435-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background A number of stent-versus-stent trials have not been able to disclose differences in stent performance. It has been hypothesized that the selection of patient subsets with simple lesion morphologies may have masked differences among the stent designs under testing. The randomized Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) trial has shown that a reduced stent strut thickness is associated with a reduced risk for restenosis. The rationale of this study was to investigate the role of lesion complexity on the capacity of a stent-versus-stent trial to distinguish between superior and inferior stents. Methods In the ISAR-STEREO trial, 651 patients were randomly assigned to receive either a thin-strut (n=326) or a thick-strut stent (n=325) with a comparable stent design. Restenosis, defined as a greater than or equal to50% diameter stenosis at follow-up angiography, was analyzed according to the lesion complexity, which was assessed with the use of the American College of Cardiology/American Heart Association classification system. Results The restenosis rate did not differ between stent designs in patients with noncomplex lesions (type A or B-1; restenosis rate: 16.7% vs 16.7%, P=1.0 for thin-strut vs thick-strut stents). In patients with complex lesions (type B-2 or C), there was a significant reduction in restenosis in the thin-strut stent group (restenosis rate: 14.5% vs 29.0%; P<.01 for thin-strut vs thick-strut stents). Conclusions The results of this study suggest that the potential to detect differences in the risk for restenosis in stent-versus-stent trials is strongly dependent on the inclusion of patients with complex lesions. These findings may be relevant when planning new stent-versus-stent trials.
引用
收藏
页码:882 / 886
页数:5
相关论文
共 13 条
  • [1] Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries
    Baim, DS
    Cutlip, DE
    O'Shaughnessy, CD
    Hermiller, JB
    Kereiakes, DJ
    Giambartolomei, A
    Katz, S
    Lansky, AJ
    Fitzpatrick, M
    Popma, JJ
    Ho, KKL
    Leon, MB
    Kuntz, RE
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (02) : 152 - 156
  • [2] Final results of a randomized trial comparing the MULTI-LINK stent with the Palmaz-Schatz stent for narrowings in native coronary arteries
    Baim, DS
    Cutlip, DE
    Midei, M
    Linnemeier, TJ
    Schreiber, T
    Cox, D
    Kereiakes, D
    Popma, JJ
    Robertson, L
    Prince, R
    Lansky, AJ
    Ho, KKL
    Kuntz, RE
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (02) : 157 - 162
  • [3] Stent-versus-stent equivalency trials - Are some stents more equal than others?
    Edelman, ER
    Rogers, C
    [J]. CIRCULATION, 1999, 100 (09) : 896 - 898
  • [4] Comparison of self-expanding and balloon-expandable stents for the reduction of restenosis
    Han, RO
    Schwartz, RS
    Kobayashi, Y
    Wilson, SH
    Mann, JT
    Sketch, MH
    Safian, RD
    Lansky, A
    Popma, J
    Fitzgerald, PJ
    Palacios, IF
    Chazin-Caldie, M
    Goldberg, S
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (03) : 253 - 259
  • [5] Kastrati A, 2000, CATHETER CARDIO INTE, V50, P290, DOI 10.1002/1522-726X(200007)50:3<290::AID-CCD5>3.0.CO
  • [6] 2-W
  • [7] Kastrati A, 2001, CIRCULATION, V103, P2816
  • [8] Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of coronary stenoses
    Lansky, AJ
    Roubin, GS
    O'Shaughnessy, CD
    Moore, PB
    Dean, LS
    Raizner, AE
    Safian, RD
    Zidar, JP
    Kerr, JL
    Popma, JJ
    Mehran, R
    Kuntz, RE
    Leon, MB
    [J]. CIRCULATION, 2000, 102 (12) : 1364 - 1368
  • [9] Comparison of gold-coated NIR stents with uncoated NIR stents in patients with coronary artery disease
    Park, SJ
    Lee, CW
    Hong, MK
    Kim, JJ
    Park, SW
    Tahk, SJ
    Jang, YS
    Seung, KB
    Yang, JY
    Jeong, MH
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (07) : 872 - +
  • [10] GUIDELINES FOR PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - A REPORT OF THE AMERICAN-HEART-ASSOCIATION AMERICAN-COLLEGE-OF-CARDIOLOGY TASK-FORCE ON ASSESSMENT OF DIAGNOSTIC AND THERAPEUTIC CARDIOVASCULAR PROCEDURES (COMMITTEE ON PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY)
    RYAN, TJ
    BAUMAN, WB
    KENNEDY, JW
    KEREIAKES, DJ
    KING, SB
    MCCALLISTER, BD
    SMITH, SC
    ULLYOT, DJ
    [J]. CIRCULATION, 1993, 88 (06) : 2987 - 3007